AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Jorey Chernett Buys 77,702 Shares of Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett bought 77,702 shares of the firm’s stock in a transaction on Thursday, March 19th. The shares were bought at an average cost of $2.64 per share, for a total transaction of $205,133.28. Following the purchase, the insider owned 6,753,761 shares of the company’s stock, valued at approximately $17,829,929.04. The trade was a 1.16% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, March 17th, Jorey Chernett purchased 83,000 shares of AirSculpt Technologies stock. The stock was purchased at an average price of $2.56 per share, with a total value of $212,480.00.
• On Monday, March 16th, Jorey Chernett acquired 105,848 shares of AirSculpt Technologies stock. The shares were purchased at an average cost of $2.43 per share, for a total transaction of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett acquired 88,000 shares of AirSculpt Technologies stock. The shares were purchased at an average cost of $2.15 per share, for a total transaction of $189,200.00.
• On Friday, March 6th, Jorey Chernett acquired 45,600 shares of AirSculpt Technologies stock. The shares were purchased at an average price of $2.00 per share, for a total transaction of $91,200.00.
• On Wednesday, March 4th, Jorey Chernett bought 30,000 shares of AirSculpt Technologies stock. The stock was purchased at an average cost of $1.87 per share, with a total value of $56,100.00.
• On Tuesday, March 3rd, Jorey Chernett bought 80,000 shares of AirSculpt Technologies stock. The stock was purchased at an average price of $1.71 per share, with a total value of $136,800.00.

AirSculpt Technologies Stock Performance

Shares of AIRS stock opened at $2.65 on Friday. The business’s 50-day moving average price is $2.27 and its 200-day moving average price is $4.58. AirSculpt Technologies, Inc. has a 12 month low of $1.51 and a 12 month high of $12.00. The firm has a market capitalization of $165.47 million, a price-to-earnings ratio of -8.83 and a beta of 2.75. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 0.63.

Institutional Investors Weigh In On AirSculpt Technologies

A number of hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets boosted its holdings in shares of AirSculpt Technologies by 239.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock worth $48,000 after buying an additional 4,199 shares in the last quarter. Aigen Investment Management LP acquired a new stake in shares of AirSculpt Technologies during the 4th quarter worth approximately $36,000. Millennium Management LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at $33,000. Virtu Financial LLC bought a new stake in shares of AirSculpt Technologies in the 4th quarter valued at $30,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in shares of AirSculpt Technologies during the 4th quarter valued at $155,000. 91.54% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, AirSculpt Technologies has an average rating of “Reduce” and an average target price of $6.00.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.